| Samuel V Lewis, MD | |
|
301 Med Tech Pkwy, Ste 200, Johnson City, TN 37604-2364 | |
| (423) 794-1300 | |
| (423) 794-1398 |
| Full Name | Samuel V Lewis |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 41 Years |
| Location | 301 Med Tech Pkwy, Johnson City, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386649119 | NPI | - | NPPES |
| 3032875 | Medicaid | TN | |
| 3032878 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 5904 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johnson City Medical Center | Johnson city, TN | Hospital |
| Franklin Woods Community Hospital | Johnson city, TN | Hospital |
| Greeneville Community Hospital | Greeneville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of Franklin Healthcare Associates, Pllc | 2466346291 | 247 |
News Archive
Every aging baby boomer listens for the footsteps of Alzheimer's, and for good reason: It's estimated that 10 million American boomers will develop the disease. The need to develop preventative strategies, ideally long before Alzheimer's destructive, clinical symptoms appear, is critical.
An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations in the gene RET, was effective at shrinking tumours in patients with nonsmall cell lung cancer (NSCLC), with a majority of patients living for more than a year without disease progression.
The Food and Drug Administration's decision next week whether to approve the first treatment for Alzheimer's disease highlights a deep division over the drug's benefits as well as criticism about the integrity of the FDA approval process.
A majority (58%) of Americans believe that the H1N1 flu is a serious health hazard, according to a new survey released today by Silverlink Communications, Inc. This represents a marked increase as compared to May 2009, when 47% of Americans held this same perception of H1N1. While most Americans believe H1N1 is a serious health hazard, less than one-third (31%) of Americans plan on getting the H1N1 flu vaccine this year, with safety and efficacy of the vaccine cited as primary barriers for not getting the vaccine. Of particular concern, less than 27% of 18 to 24 year olds, a high risk group, plan on getting the H1N1 vaccine.
› Verified 9 days ago
| Entity Name | State Of Franklin Healthcare Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063459410 PECOS PAC ID: 2466346291 Enrollment ID: O20040211001101 |
News Archive
Every aging baby boomer listens for the footsteps of Alzheimer's, and for good reason: It's estimated that 10 million American boomers will develop the disease. The need to develop preventative strategies, ideally long before Alzheimer's destructive, clinical symptoms appear, is critical.
An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations in the gene RET, was effective at shrinking tumours in patients with nonsmall cell lung cancer (NSCLC), with a majority of patients living for more than a year without disease progression.
The Food and Drug Administration's decision next week whether to approve the first treatment for Alzheimer's disease highlights a deep division over the drug's benefits as well as criticism about the integrity of the FDA approval process.
A majority (58%) of Americans believe that the H1N1 flu is a serious health hazard, according to a new survey released today by Silverlink Communications, Inc. This represents a marked increase as compared to May 2009, when 47% of Americans held this same perception of H1N1. While most Americans believe H1N1 is a serious health hazard, less than one-third (31%) of Americans plan on getting the H1N1 flu vaccine this year, with safety and efficacy of the vaccine cited as primary barriers for not getting the vaccine. Of particular concern, less than 27% of 18 to 24 year olds, a high risk group, plan on getting the H1N1 vaccine.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samuel V Lewis, MD 301 Med Tech Pkwy, Ste 200, Johnson City, TN 37604-2364 Ph: (423) 794-1300 | Samuel V Lewis, MD 301 Med Tech Pkwy, Ste 200, Johnson City, TN 37604-2364 Ph: (423) 794-1300 |
News Archive
Every aging baby boomer listens for the footsteps of Alzheimer's, and for good reason: It's estimated that 10 million American boomers will develop the disease. The need to develop preventative strategies, ideally long before Alzheimer's destructive, clinical symptoms appear, is critical.
An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations in the gene RET, was effective at shrinking tumours in patients with nonsmall cell lung cancer (NSCLC), with a majority of patients living for more than a year without disease progression.
The Food and Drug Administration's decision next week whether to approve the first treatment for Alzheimer's disease highlights a deep division over the drug's benefits as well as criticism about the integrity of the FDA approval process.
A majority (58%) of Americans believe that the H1N1 flu is a serious health hazard, according to a new survey released today by Silverlink Communications, Inc. This represents a marked increase as compared to May 2009, when 47% of Americans held this same perception of H1N1. While most Americans believe H1N1 is a serious health hazard, less than one-third (31%) of Americans plan on getting the H1N1 flu vaccine this year, with safety and efficacy of the vaccine cited as primary barriers for not getting the vaccine. Of particular concern, less than 27% of 18 to 24 year olds, a high risk group, plan on getting the H1N1 vaccine.
› Verified 9 days ago
Lauryn Camille Gabby, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2335 Knob Creek Rd Ste 100, Johnson City, TN 37604 Phone: 423-430-9942 | |
Martin E. Olsen, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 325 N State Of Franklin Rd Fl 1, Johnson City, TN 37604 Phone: 423-439-7272 Fax: 423-439-7235 | |
Dr. Molly Talcott Heinzen Oxford, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 325 N State Of Franklin Rd Fl 1, Johnson City, TN 37604 Phone: 423-439-7272 Fax: 423-439-7235 | |
Brian H Dunkelberger, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 301 Med Tech Pkwy, Ste. 200, Johnson City, TN 37604 Phone: 423-794-1300 Fax: 423-794-1820 | |
Marcia M Sentell, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 301 Med Tech Pkwy, Ste 200, Johnson City, TN 37604 Phone: 423-794-1300 Fax: 423-794-1820 | |
Dr. Blake T Rozycki, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 301 Med Tech Pkwy Ste 200, Johnson City, TN 37604 Phone: 423-794-1300 Fax: 423-794-1820 | |
Tara Vick, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 325 N State Of Franklin Rd Fl 1, Johnson City, TN 37604 Phone: 423-439-7272 |